Biotech funder BioProjects floats on UK's AIM (Alternative Investment Market)
This article was originally published in Clinica
Executive Summary
UK biotech project funder and strategic consultant BioProjects International has raised £4.5 million ($6.5 million) in its flotation of 75 million shares (29% of capital) on the UK's Alternative Investment Market. The placing, at 6p per share, values the company at £15.12 million.